Media OutReach
HKUST Announces the Appointment of Prof. King Li as the Founding Dean of Medicine
Following a rigorous global search, Prof. Li was selected for his exceptional track record in academic leadership, medical education, and biomedical innovation, as well as his unique experience in founding a new medical school.
Prof. Li previously served as Founding Dean of the Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign (UIUC) from 2016 to 2021—one of the world’s pioneering engineering-based medical schools. During his tenure, he played a pivotal role in developing a technology-oriented curriculum, recruiting founding faculty, and building academic-clinical partnerships. Under his leadership, the College’s early graduating cohorts achieved a 100% pass rate in licensing examinations, reflecting the outstanding quality and rigorous standards of the programme.
An internationally distinguished physician-scientist and biomedical innovator, Prof. Li currently holds the titles of Dean Emeritus and Professor Emeritus at the Carle Illinois College of Medicine, as well as Adjunct Professor of Radiology at Stanford University School of Medicine. His career spans leading institutions including Stanford University, the U.S. National Institutes of Health, Weill Cornell Medical College, Wake Forest School of Medicine, and UIUC. He holds a Doctor of Medicine (with Honours) from the University of Toronto and an MBA from San José State University.
Prof. Li’s appointment comes at a pivotal moment as HKUST advances its plans to establish a new School of Medicine. The School will offer a four-year graduate-entry MBBS programme, with its inaugural cohort expected to commence in the 2028/29 academic year.
His experience aligns closely with HKUST’s vision to develop a future-ready medical school that integrates clinical excellence with engineering, data science, and emerging technologies. His proven approach to training physician-innovators—combining strong clinical foundations with interdisciplinary expertise—will provide a robust foundation for the School’s development, while being adapted to HKUST’s unique strengths in science and technology.
Known for his commitment to interdisciplinary collaboration, Prof. Li has consistently bridged fields such as radiology, bioengineering, computer science, and nanotechnology—an approach that will be instrumental in shaping HKUST’s innovative model of medical education.
Beyond medical education, Prof. Li is a highly accomplished innovator. He is a Fellow of the US National Academy of Inventors and has received the Gold Medal of the Association of University Radiologists. He is also a Fellow of several leading professional bodies, including the American College of Radiology, the American Institute for Medical and Biological Engineering, and the International Society for Magnetic Resonance in Medicine. He holds 20 issued patents across the United States, Australia, and Europe, and has founded a company based on his translational research.
Prof. Harry SHUM, Chairman of HKUST Council, said, “I would like to extend my warmest welcome to Prof. Li on his appointment as our Founding Dean of the School of Medicine. His proven expertise and experience are invaluable to the University as we plan to develop a distinctive model of medical education for the future. We have full confidence in his exceptional leadership in spearheading our medical school, which is one of the most significant undertakings in HKUST’s 35‑year history. The Council is committed to giving its support to ensure the success of the School.”
Prof. Nancy IP, President of HKUST, said, “Prof. Li brings a rare combination of founding dean experience, academic excellence, and a forward-looking vision for technology-driven medical education. His leadership will be central to building a medical school that is globally competitive, locally relevant, and impactful for Hong Kong and the wider region. We warmly welcome Prof. Li to the University and look forward to his leadership in the establishment of the HKUST School of Medicine, as well as in shaping a new generation of medical professionals and advancing innovation in healthcare. I also extend our sincere appreciation to the Search Committee, chaired by Ms. Edith SHIH (Vice-Chairperson of the Council), and its members including Prof. FOK Tai-Fai and Prof. Raymond LIANG for their dedication and diligence in completing this important international recruitment process.”
Prof. King Li, Founding Dean of the School of Medicine, said,”I am deeply honoured to be appointed as the Founding Dean of HKUST’s new School of Medicine. Returning to Hong Kong—where my roots are—to take on this role at HKUST and having the chance to give back through the place I grew up, is deeply meaningful to me. HKUST has a remarkable track record of turning bold visions into reality, and I am excited to build a medical school that reimagines physician training through the integration of engineering, data science, and biomedical innovation. Drawing on my experience and working closely with our partners in Hong Kong and the Greater Bay Area, I look forward to nurturing a new generation of physician-innovators who will transform healthcare for the benefit of patients and society.”
Born and raised in Hong Kong, Prof. Li brings with him a strong personal commitment to advancing Hong Kong as an international hub for medical education and innovation. He has long-standing ties with the local academic and medical communities.
The University community is expected to provide its full support to Prof. Li as he expands partnerships with teaching hospitals, the government, industry, and the global medical community, and further strengthens connections with the Greater Bay Area and other regions.
Hashtag: #HKUST
The issuer is solely responsible for the content of this announcement.
About The Hong Kong University of Science and Technology
The Hong Kong University of Science and Technology (HKUST) (
https://hkust.edu.hk/) is a world-class university known for its innovative education, research excellence, and impactful knowledge transfer. With a holistic and interdisciplinary pedagogy approach, HKUST was ranked 6th in the QS Asia University Rankings 2026, 3rd in the Times Higher Education’s Young University Rankings 2024, and 19th globally and 1st in Hong Kong in the Times Higher Education’s Impact Rankings 2025. Eleven HKUST subjects were ranked among the world’s top 50 in the QS World University Rankings by Subject 2026. In addition, in the Times Higher Education World University Rankings by Subject 2026, HKUST’s Computer Science discipline which encompasses areas such as artificial intelligence and machine learning, has been ranked No. 1 in Hong Kong for ten consecutive years. Our graduates are highly competitive, consistently ranking among the world’s top 30 most sought-after employees. In terms of research and entrepreneurship, over 80% of our work was rated “internationally excellent” or “world leading” in the Research Assessment Exercise 2020 of the Hong Kong’s University Grants Committee. As of May 2026, HKUST members have founded over 1,900 active start-ups, including 11 Unicorns and 22 exits (IPO or M&A).
Through DaaS, enterprise customers can access drone equipment, trained personnel, mission execution, data collection and project deliverables without purchasing and maintaining a complete in-house drone system. The model extends ZenaTech’s business beyond equipment sales and enables the company to generate recurring service revenue from customers’ operational requirements.
ZenaTech reported revenue of CAD 8.4 million for the first quarter of 2026, an increase of 640% from CAD 1.13 million in the same period of 2025. DaaS contributed approximately CAD 7.8 million, accounting for around 93% of quarterly revenue.
In 2025, the company generated annual revenue of CAD 12.9 million, up 558% from approximately CAD 2 million in 2024. DaaS contributed approximately CAD 10.1 million during its first full year of operations, representing around 78% of total annual revenue.
Acquisitions Support Service Network Expansion
ZenaTech has expanded its DaaS operations through a combination of internal technology development and acquisitions. The acquired businesses bring existing customers, professional teams and local operating capabilities, while ZenaTech gradually introduces drones, automated data collection and AI-supported analytics into selected workflows.
In 2025, the company completed 20 acquisitions, including 19 businesses providing engineering data, facility inspection and related professional services, as well as one enterprise software company.
By June 2026, ZenaTech had completed its 24th DaaS-related acquisition and expanded its services into property cleaning, facility inspection and maintenance.
Through its ZenaDrone subsidiary, ZenaTech has also developed drone products for indoor and outdoor operations. The IQ Quad supports site data collection, engineering imagery and 3D modelling, while the IQ Nano uses barcode and RFID scanning to support inventory records, shelf inspections and indoor data collection.
The company’s reported revenue growth, acquisition activity and DaaS contribution provide investors following the AI and drone sectors with measurable indicators of how its technologies are being integrated into commercial operations and converted into service revenue.
Hashtag: #ZenaTech
The issuer is solely responsible for the content of this announcement.
About ZenaTech
ZenaTech (Nasdaq: ZENA) is a technology company specialising in AI-powered drones, Drone-as-a-Service (DaaS), enterprise SaaS solutions and related technologies. Through its ZenaDrone subsidiary, the company develops drone products and software for commercial applications including engineering data collection, agriculture, warehouse management, facility inspection and property maintenance. ZenaTech combines its technology capabilities with a growing professional service network to support the adoption of drone-based solutions across a range of operational environments.
Media OutReach
A Defining Milestone for Gene Solutions: SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation
The proposed indications for use describe SPOT-MAS 10 as a qualitative in vitro diagnostic test performed on plasma derived from a single direct-draw venous whole blood specimen. The test analyzes circulating cell-free DNA methylation and fragmentomic signatures using a machine-learning-based algorithm to detect a cancer-associated signal. It is intended for use as an adjunctive screening test in asymptomatic adults aged 40 years and older to assist in detecting cancers within the scope of the assay. These include five common cancers — breast, lung, liver, colorectal and gastric cancers — and five aggressive, less common cancers that currently lack standard screening methods — ovarian, pancreatic, esophageal, endometrial and head & neck cancers.
SPOT-MAS has been developed through years of rigorous scientific research and clinical development. In March 2025, SPOT-MAS became the first multi-cancer screening blood test in Asia to complete a large prospective cohort validation, with the K-DETEK study evaluating more than 9,000 asymptomatic participants and demonstrating strong performance, including high specificity and the ability to identify cancer-associated signals across multiple cancer types.
Since then, SPOT-MAS has been used in more than 100,000 individuals in real-world practice, with consistent performance observed beyond controlled study settings. Real-world data were presented at ESMO Asia 2025 and were featured at ASCO Breakthrough 2026 in Singapore.
The platform is built on a multi-omic approach— integrating genetics, epigenetics, and fragmentomics — together with AI-driven analysis, large-scale prospective validation, growing real-world evidence and focus on cancer types with high clinical relevance in the regions where the test is deployed.
For the United States, Breakthrough Device Designation provides Gene Solutions with a prioritized channel of engagement with the FDA as the company advances its U.S. development and validation plans.
Looking ahead, Gene Solutions will continue to collaborate with academic, clinical, laboratory, commercial and strategic partners to support responsible adoption of SPOT-MAS in accordance with local regulations, clinical guidelines and best practices.
Important Regulatory Notice: SPOT-MAS 10 has received U.S. FDA Breakthrough Device Designation. Breakthrough Device Designation is not FDA approval, clearance or marketing authorization. The device remains subject to applicable FDA regulatory review requirements, and the designation does not guarantee future FDA approval, clearance or authorization.
For more information, visit https://spotmas.com.hk
Contact:
hk***@***********ns.com
Source: Gene Solutions Hong Kong Limited.
SPOTMAS_062026_04
Hashtag: #SPOTMAS
https://spotmas.com.hk/The issuer is solely responsible for the content of this announcement.
Media OutReach
St Francis Methodist School International Shares 2023–2024 WACE Outcomes and Student Journeys
Overview of the WACE Curriculum at SFMS
SFMS International is among a small number of institutions in Singapore offering the WACE curriculum and has delivered this programme for over 23 years. The WACE is a recognised senior secondary qualification awarded by the School Curriculum and Standards Authority (SCSA) on behalf of the Ministry of Education, Western Australia. It prepares students for university admission both locally and internationally.
SFMS is also currently the only school in Singapore offering a Senior High Preparatory Pathway (WACE) for students in Years 9–10. This introduces students to the structure and expectations of the curriculum earlier, building familiarity with subject content and assessment formats before progressing to the senior years. Additionally, subject selection in Years 11A and 12A is structured to meet university entry requirements and reflect students’ academic interests.
Academic Outcomes and University Placements
In 2023, 8 out of 12 WACE graduates from SFMS International achieved ATAR scores above 90, meeting the eligibility criteria for universities such as the National University of Singapore (NUS) and Nanyang Technological University (NTU). The cohort’s top scorer, Wang Dawei, recorded an ATAR of 96.15 and enrolled at NTU to study Business and International Trading. In addition to local placements, graduates were admitted to international universities such as the University of Melbourne and Fudan University in China.
In 2024, 2 out of 8 graduates also attained ATAR scores above 90. The highest scorer, Youn Chae-Won, achieved an ATAR of 95.3. Her university placement is currently pending.
Student Journeys and Holistic Development
Students in the WACE programme at SFMS International engage in both academic and co-curricular activities as part of their overall learning experience. Recent graduates have taken part in service learning, subject specialisation, and personal reflection throughout their time in the pre-university programme.
Youn Chae-Won, the 2024 valedictorian, joined SFMS International from Korea in 2021. Over time, she adjusted to a new academic environment and explored subjects such as accounting, which influenced her interest in finance-related pathways. She also took part in various aspects of school life, including a service learning trip to Bintan in 2023, where students supported local sanitation efforts. Her involvement in both academic and co-curricular settings marked a broad engagement with school life during her time at SFMS.
Andrew Zhuang, who enrolled in SFMS International in 2019, pursued subjects such as Business Management, Accounting, and English as an Additional Language (EALD). Beyond academics, he was involved in community fundraising and joined the same Bintan service trip. He also attended weekly chapel sessions and received support from peers and teachers during a period of health-related absence.
These outcomes reflect the ongoing role of the WACE programme at SFMS International in supporting students through both academic pathways and broader educational experiences. Under the leadership of Principal Mr Lee Hak Boon, the school continues to emphasise academic planning, subject selection, and student wellbeing as part of its overall approach to pre-university education.
Hashtag: #StFrancisMethodistSchoolInternational
https://www.sfms.edu.sg/
https://www.facebook.com/sfms.singapore
https://www.instagram.com/sfms_sg/
https://www.youtube.com/channel/UC_bb9hcNhAk7WgYBE_FI61A/featured
The issuer is solely responsible for the content of this announcement.
About St Francis Methodist School International
Established in 1960, St Francis Methodist School International (SFMS) is an educational institution in Singapore that offers primary, secondary, and pre-university programmes. The school provides several academic pathways, including the International Baccalaureate (IB), Cambridge IGCSE, and the Western Australian Certificate of Education (WACE), preparing students for further studies in local and overseas institutions.
